Journal · 101647039
EBioMedicine
2 sourcesjournal-index-2026-11-06-0.2.0
Download JSON
Cite this record
ConductScience Library. EBioMedicine. Journal index, record 101647039. Release journal-index-2026-11-06-0.2.0, 6 Nov 2026. https://conductscience.org/library/journal-index/101647039
On this page
Journal
Counted by ScienceGraph from its copy of PubMed, by the NLM ID each paper's record states: papers from 1959 on, and no preprints, since until the copy is rebuilt from NLM's own files it holds few of PubMed's papers from before 1959 and about half its preprints.
Years13
Each paper counts in the year of its issue, as its record states. PubMed's search for a year also finds papers that appeared online that year, so its count can be higher. A part year is our copy's own year or later.
| Year | Papers | With a copy in PMC | Retracted | With NIH grants | With a ClinicalTrials.gov number | Source |
|---|---|---|---|---|---|---|
| 2026, part year | 471 | 457 | 0 | 74 | 9 | PubMed |
| 2025 | 558 | 558 | 0 | 104 | 9 | PubMed |
| 2024 | 571 | 571 | 0 | 130 | 8 | PubMed |
| 2023 | 499 | 499 | 0 | 119 | 11 | PubMed |
| 2022 | 622 | 622 | 0 | 134 | 14 | PubMed |
| 2021 | 597 | 597 | 0 | 118 | 9 | PubMed |
| 2020 | 568 | 568 | 3 | 106 | 10 | PubMed |
| 2019 | 787 | 787 | 5 | 153 | 13 | PubMed |
| 2018 | 495 | 495 | 3 | 77 | 7 | PubMed |
| 2017 | 393 | 393 | 0 | 66 | 9 | PubMed |
1 to 10 of 13
See all 13 yearsPublication types43
NLM's publication types, as each record states them. A paper can have several.
Retracted papers11
Papers whose PubMed record is typed Retracted Publication, with the notice PubMed links.
| PMID | Title | Year | Retraction notice | Source |
|---|---|---|---|---|
| 32858399 | Effect of antenatal magnesium sulphate on MRI biomarkers of white matter development at term equivalent age: The magnum study. | 2020 | 35393264 | PubMed |
| 32416443 | Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]. | 2020 | 38579361 | PubMed |
| 32335370 | Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter. | 2020 | 38833838 | PubMed |
| 31727599 | RETRACTED: LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN. | 2019 | 34717838 | PubMed |
| 31530503 | RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells. | 2019 | 34717839 | PubMed |
| 31383552 | MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway. | 2019 | 38579362 | PubMed |
| 31201145 | LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN. | 2019 | 38833840 | PubMed |
| 31097406 | R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling. | 2019 | 40467421 | PubMed |
| 30389502 | The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC. | 2018 | 33487223 | PubMed |
| 30146342 | The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells. | 2018 | 33487222 | PubMed |
1 to 10 of 11
See all 11 retracted papersNewest papers20
The twenty newest papers in our copy of PubMed, by year and then PMID.
| PMID | Title | Year | Source |
|---|---|---|---|
| 42981739 | A randomised, double-blind, multicentre, placebo-controlled phase 3 efficacy, safety, and immunogenicity study of an Ad26.RSV.preF/RSV prefusion F-protein vaccine for the prevention of respiratory syncytial virus-mediated lower respiratory tract disease in adults aged 60 years and older. | 2026 | PubMed |
| 42976400 | Integrative analysis of single-cell, bulk RNA-sequencing and biobank-scale genomic data reveals the bidirectional mediation and joint effects between proportion of beta cells and BMI for type 2 diabetes. | 2026 | PubMed |
| 42971819 | Potential biomarker candidates for improving diagnosis and disease treatment in adenomyosis. | 2026 | PubMed |
| 42971818 | Decoding adenomyosis: integrative insights from genetics, multiomics, and advanced computational analyses. | 2026 | PubMed |
| 42970858 | Non-invasive quantification of lower airway antigen-specific antibodies using exhaled breath particles - an observational proof-of-concept study. | 2026 | PubMed |
| 42962556 | Unravelling the biological divergence of CD30+ lymphoproliferative disorders with skin involvement: from clinical risk to precision oncology. | 2026 | PubMed |
| 42962555 | Gut microbial functional associations with subsequent irritable bowel syndrome in a prospective, paediatric case-control study. | 2026 | PubMed |
| 42956541 | Advances in the management of pneumonia caused by drug-resistant bacteria: from antimicrobial optimisation to integrated treatment adaptation. | 2026 | PubMed |
| 42956540 | Serum neurofilament light chain and the 2024 McDonald criteria for multiple sclerosis: a retrospective cohort study. | 2026 | PubMed |
| 42956539 | Identification of peptide epitopes in major antigens of Yersinia pestis from infected humans and immunised mice. | 2026 | PubMed |
| 42945895 | Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study. | 2026 | PubMed |
| 42945894 | Associations between salivary HHV-6 and long COVID severity in a cross-sectional, case-control analysis. | 2026 | PubMed |
| 42945893 | Evaluation of Andes virus vaccine-derived human antibody for protection in Syrian hamsters: a passive transfer study using phase 1 trial sera. | 2026 | PubMed |
| 42933106 | Alcohol disrupts spatial coordination of autophagy-lysosome pathways to impair intestinal barrier integrity. | 2026 | PubMed |
| 42925816 | Lipid dynamics and cardiovascular risk profiles on carbohydrate- or saturated fat-based diets: secondary analysis of the CARBFUNC trial. | 2026 | PubMed |
| 42919698 | Mapping human genetic associations to drug targets in valvular heart disease: an integrative evidence synthesis. | 2026 | PubMed |
| 42914928 | Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. | 2026 | PubMed |
| 42913305 | Predictors of HIV reservoir size and decay dynamics in early-treated paediatric infection: a prospective, multicentre longitudinal cohort study. | 2026 | PubMed |
| 42913304 | Cataract genetics: bringing disease modification into focus. | 2026 | PubMed |
| 42913303 | Infant gut microbiome neuroactive pathways link to social disadvantage, toddler neurodevelopment, cognitive and behavioural outcomes: a longitudinal cohort study. | 2026 | PubMed |
Data dates
The date of each source this release read.
- Our copy of PubMed
- 2026-11-06
- NLM's journal list
- 2026-11-01
Sources 2
- NLM's journal listNLM's terms
- PubMedNLM's terms
Each source's terms
- NLM's journal listNLM's
- PubMedNLM's terms
For software
Read this journal from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/journal-index/v1/101647039
GET https://conductscience.org/api/journal-index/v1/101647039/types?page=2